Fetal and maternal outcome in asymptomatic bacilluria of pregnancy. Effects on isohemagglutinin titers.
D000037:Abruptio Placentae / Q000150:complications; D000917:Antibody Formation; D001437:Bacteriuria / Q000150:complications* / Q000188:drug therapy; D004927:Escherichia coli Infections; D005321:Extraembryonic Membranes; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000276:immunology*; D007518:Isoantibodies; D008431:Maternal-Fetal Exchange; D009582:Nitrofurantoin / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000150:complications; D011225:Pre-Eclampsia / Q000150:complications; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000150:complications* / Q000188:drug therapy; D012421:Rupture; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014470:Umbilical Cord
D007518:Isoantibodies; D009582:Nitrofurantoin; D013420:Sulfamethoxazole